• Company Type For Profit
  • Phone Number 651-730-1008
Travanti Pharma is a privately held corporation that designs, develops and markets innovative drug delivery platforms that improve the safety, compliance, effectiveness and ease of administration of medications, which are delivered into the body.

Lists Featuring This Company

Minnesota Companies that Exited
1,592 Number of Organizations â€¢ $24.2B Total Funding Amount â€¢ 907 Number of Investors
Closed Midwestern US Companies
9,206 Number of Organizations â€¢ $24.7B Total Funding Amount â€¢ 3,527 Number of Investors
Midwestern US Companies that Exited (Top 10K)
9,841 Number of Organizations â€¢ $322.5B Total Funding Amount â€¢ 6,207 Number of Investors
Closed United States Biotechnology Companies
2,257 Number of Organizations â€¢ $65.8B Total Funding Amount â€¢ 4,736 Number of Investors
Travanti Pharma was acquired by Teikoku Pharma on May 8, 2009.

Frequently Asked Questions

Where is Travanti Pharma's headquarters? Travanti Pharma is located in Mendota, Minnesota, United States.Who invested in Travanti Pharma? Travanti Pharma has 2 investors including Spring Bay Ventures and Prolog Ventures.How much funding has Travanti Pharma raised to date? Travanti Pharma has raised .When was the last funding round for Travanti Pharma? Travanti Pharma closed its last funding round on Jul 27, 2006 from a Series B round.Who are Travanti Pharma's competitors? Alternatives and possible competitors to Travanti Pharma may include CEL-SCIAzaya Therapeutics, and Sitari Pharmaceuticals.